Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Secondary Obliteration of Chronically Discharging Old Radical Cavities Using S53P4 Bioactive Glass

NCT06116513 is registered in ClinicalTrials.gov with Diakonessenhuis, Utrecht as lead sponsor.

NCT NCT06116513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06116513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Secondary Obliteration of Chronically Discharging Old Radical Cavities Using S53P4 Bioactive Glass
Lead sponsor
Diakonessenhuis, Utrecht
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2021
Completion date
January 1, 2024
Enrollment
97 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mastoid cavity